Neozyme International, Inc. Announces Successful Increase in Dissolved Oxygen in Leachate From Major Landfill Site in Pennsylvania ALISO VIEJO, Calif., Nov. 11 /PRNewswire/ -- Neozyme International, Inc. (Neozyme), a subsidiary of International Daleco Corporation (Pink Sheets: ILDO), is pleased to announce the successful increase in dissolved oxygen (DO) in a packed bed reactor site. The reactor treats leachate from a major landfill facility in Pennsylvania. The site is receiving twice the organic load it was designed for and has been unable to reduce the organic load required by a county wastewater treatment plant. The plant and discharge lines have heavy hydrogen sulfide gases. By adding Neozyme's bio-organic catalyst, the organic discharge was reduced 60%, the hydrogen sulfide gases were substantially reduced and the DO was increased fourfold in ten days. Eighty-two percent of all U.S. municipal solid waste (roughly 134 million tons annually) ends up in the nation's more than 7,500 landfills. The ability to non-mechanically increase DO, with just parts per million of our liquid catalyst, is a major breakthrough of Neozyme's patented bio-organic technology. By increasing the DO, organic loads can be quickly reduced in any body of water, whether it is a municipal wastewater plant, industrial treatment plant, lake, river or ocean. Neozyme manufactures and sells its patented line of bio-organic catalytic formulations for numerous markets including, but not limited to, municipal wastewater treatment, commercial/industrial, hydrocarbon remediation, industrial metal cleaning and agriculture. All Neozyme products are non-toxic, 100% biodegradable and can be safely used around humans, animals, marine life, vegetation and the environment. No special clothing or handling apparatus is required. For more information, please visit http://www.daleco.com/ . This News Release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on the Company's expectations of forecasts of future events, can be affected by inaccurate assumptions and are subject to various risks and known and unknown uncertainties, a number of which are beyond the Company's control. Therefore, actual results could differ materially from the forward-looking statements herein. DATASOURCE: Neozyme International, Inc. CONTACT: Parker Dale, Chairman of International Daleco Corporation, +1-949-360-4288, or fax, +1-949-360-8774, or email, Web site: http://www.daleco.com/

Copyright